Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jul 5;91(14):6688-92.
doi: 10.1073/pnas.91.14.6688.

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage

Affiliations

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage

A Friedman et al. Proc Natl Acad Sci U S A. .

Abstract

Oral tolerance was generated to hen egg white lysozyme in the mouse or to guinea pig myelin basic protein in the rat by a low-dose (1 mg) or a high-dose (5-20 mg) feeding regimen. High doses of antigen induced tolerance characterized by anergy with little or no active suppression and increased secretion of interleukin 4 (IL-4). Anergy was shown by an increase in frequency of IL-2-secreting cells following culture in recombinant IL-2. Low doses of antigen induced tolerance characterized by antigen-driven active suppression with increased secretion of transforming growth factor beta (TGF-beta) and IL-4 and minimal anergy. Without further immunization, spleen cells from animals orally tolerized by both regimens secreted increased levels of IL-4 and TGF-beta in an antigen-specific manner. Animals fed high doses secreted more IL-4 and less TGF-beta, whereas those fed low doses secreted more TGF-beta and less IL-4. These results demonstrate that the two feeding regimens induced cell populations that differed in their cytokine secretion profile and their capacity to actively suppress in vitro and to induce anergy. Our results provide a basis for distinguishing different forms of antigen-driven peripheral tolerance and have important implications for orally induced antigen-specific modulation of human autoimmune diseases.

PubMed Disclaimer

References

    1. Eur J Immunol. 1993 Jan;23(1):46-55 - PubMed
    1. Immunol Today. 1992 Sep;13(9):348-52 - PubMed
    1. Science. 1993 Feb 26;259(5099):1321-4 - PubMed
    1. Eur J Immunol. 1993 Apr;23(4):935-42 - PubMed
    1. J Neuroimmunol. 1993 Jul;46(1-2):73-82 - PubMed

Publication types

MeSH terms

LinkOut - more resources